COMPANY NEWS


Suven Pharmaceuticals Ltd
BSE Code 543064 ISIN Demat INE03QK01018 Book Value (₹) 76.54 NSE Symbol SUVENPHAR Div & Yield % 0.93 Market Cap ( Cr.) 16,437.26 P/E * 43.08 EPS * 14.99 Face Value (₹) 1
* Profit to Earning Ratio
* Earning Per Share
Board of Suven Pharmaceuticals approves scheme of amalgamation Back
(29 Feb 2024)
The Board of Suven Pharmaceuticals at its meeting held on 29 February 2024 has approved a scheme of amalgamation of Cohance Lifesciences (transferor company) into and with the Company.